Set-valued dynamic treatment regimes for competing outcomes

Biometrics. 2014 Mar;70(1):53-61. doi: 10.1111/biom.12132. Epub 2014 Jan 8.

Abstract

Dynamic treatment regimes (DTRs) operationalize the clinical decision process as a sequence of functions, one for each clinical decision, where each function maps up-to-date patient information to a single recommended treatment. Current methods for estimating optimal DTRs, for example Q-learning, require the specification of a single outcome by which the "goodness" of competing dynamic treatment regimes is measured. However, this is an over-simplification of the goal of clinical decision making, which aims to balance several potentially competing outcomes, for example, symptom relief and side-effect burden. When there are competing outcomes and patients do not know or cannot communicate their preferences, formation of a single composite outcome that correctly balances the competing outcomes is not possible. This problem also occurs when patient preferences evolve over time. We propose a method for constructing DTRs that accommodates competing outcomes by recommending sets of treatments at each decision point. Formally, we construct a sequence of set-valued functions that take as input up-to-date patient information and give as output a recommended subset of the possible treatments. For a given patient history, the recommended set of treatments contains all treatments that produce non-inferior outcome vectors. Constructing these set-valued functions requires solving a non-trivial enumeration problem. We offer an exact enumeration algorithm by recasting the problem as a linear mixed integer program. The proposed methods are illustrated using data from the CATIE schizophrenia study.

Trial registration: ClinicalTrials.gov NCT00014001.

Keywords: Competing outcomes; Composite outcomes; Dynamic treatment regimes; Personalized medicine; Preference elicitation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Algorithms
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Body Mass Index
  • Clinical Protocols*
  • Clinical Trials as Topic / methods*
  • Decision Making*
  • Humans
  • Models, Statistical*
  • Schizophrenia / drug therapy
  • Treatment Outcome*

Substances

  • Antipsychotic Agents

Associated data

  • ClinicalTrials.gov/NCT00014001